Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.

Mannino GC, Pezzilli S, Averta C, Fuoco A, Spiga R, Mancuso E, Di Fatta C, Perticone F, Prudente S, Trischitta V, Andreozzi F, Sesti G.

Cardiovasc Diabetol. 2019 Aug 13;18(1):102. doi: 10.1186/s12933-019-0906-1.

2.

Acute post-traumatic hydrocephalus in children due to aqueductal obstruction by blood clot: a series of 6 patients.

Spennato P, Ruggiero C, Parlato RS, Trischitta V, Mirone G, De Santi MS, Cinalli G.

Childs Nerv Syst. 2019 Nov;35(11):2037-2041. doi: 10.1007/s00381-019-04318-6. Epub 2019 Jul 25.

PMID:
31346735
3.

Association of a homozygous GCK missense mutation with mild diabetes.

Marucci A, Biagini T, Di Paola R, Menzaghi C, Fini G, Castellana S, Cardinale GM, Mazza T, Trischitta V.

Mol Genet Genomic Med. 2019 Jul;7(7):e00728. doi: 10.1002/mgg3.728. Epub 2019 Jun 14.

4.

Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model.

Copetti M, Shah H, Fontana A, Scarale MG, Menzaghi C, De Cosmo S, Garofolo M, Sorrentino MR, Lamacchia O, Penno G, Doria A, Trischitta V.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4900-4908. doi: 10.1210/jc.2019-00215.

PMID:
31087060
5.

GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling.

Marucci A, Antonucci A, De Bonis C, Mangiacotti D, Scarale MG, Trischitta V, Di Paola R.

Int J Obes (Lond). 2019 Dec;43(12):2448-2457. doi: 10.1038/s41366-019-0367-3. Epub 2019 Apr 30.

PMID:
31040393
6.

Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation.

Haydar S, Grigorescu F, Vintilă M, Cogne Y, Lautier C, Tutuncu Y, Brun JF, Robine JM, Pugeat M, Normand C, Poucheret P, Gheorghiu ML, Georgescu C, Badiu C, Băculescu N, Renard E, Ylli D, Badiou S, Sutra T, Cristol JP, Mercier J, Gomis R, Macias JM, Litvinov S, Khusnutdinova E, Poiana C, Pasquali R, Lauro D, Sesti G, Prudente S, Trischitta V, Tsatsoulis A, Abdelhak S, Barakat A, Zenati A, Ylli A, Satman I, Kanninen T, Rinato Y, Missoni S.

PLoS One. 2019 Mar 26;14(3):e0214122. doi: 10.1371/journal.pone.0214122. eCollection 2019.

7.

Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing.

Dallali H, Pezzilli S, Hechmi M, Sallem OK, Elouej S, Jmel H, Ben Halima Y, Chargui M, Gharbi M, Mercuri L, Alberico F, Mazza T, Bahlous A, Ben Ahmed M, Jamoussi H, Abid A, Trischitta V, Abdelhak S, Prudente S, Kefi R.

Acta Diabetol. 2019 May;56(5):515-523. doi: 10.1007/s00592-018-01283-5. Epub 2019 Jan 17.

PMID:
30656436
8.

Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes.

Bertoccini L, Bailetti D; SUMMER Study in Diabetes Group, Buzzetti R, Cavallo MG, Copetti M, Cossu E, D'Angelo P, De Cosmo S, Di Mauro L, Leonetti F, Morano S, Morviducci L, Napoli N, Prudente S, Pugliese G, Trischitta V, Baroni MG.

Oncotarget. 2018 Oct 9;9(79):34911-34918. doi: 10.18632/oncotarget.26178. eCollection 2018 Oct 9.

9.

Circulating adiponectin levels are paradoxically associated with mortality rate. A systematic review and meta-analysis.

Scarale MG, Fontana A, Trischitta V, Copetti M, Menzaghi C.

J Clin Endocrinol Metab. 2018 Nov 1. doi: 10.1210/jc.2018-01501. [Epub ahead of print]

PMID:
30388239
10.

Erratum. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. Diabetes 2018;67:12-22.

Menzaghi C, Trischitta V.

Diabetes. 2018 Dec;67(12):2710. doi: 10.2337/db18-er12a. Epub 2018 Oct 10. No abstract available.

11.

Branched-Chain Amino Acid Database Integrated in MEDIPAD Software as a Tool for Nutritional Investigation of Mediterranean Populations.

Haydar S, Paillot T, Fagot C, Cogne Y, Fountas A, Tutuncu Y, Vintila M, Tsatsoulis A, Thanh Chi P, Garandeau P, Chetea D, Badiu C, Gheorghiu M, Ylli D, Lautier C, Jarec M, Monnier L, Normand C, Šarac J, Barakat A, Missoni S, Pugeat M, Poucheret P, Hanzu F, Gomis R, Macias JM, Litvinov S, Khusnutdinova E, Poiana C, Pasquali R, Lauro D, Sesti G, Trischitta V, Abdelhak S, Zenati A, Ylli A, Satman I, Kanninen T, Rinato Y, Grigorescu F.

Nutrients. 2018 Oct 1;10(10). pii: E1392. doi: 10.3390/nu10101392.

12.

Is There Really a Paradoxical Effect of Obesity on Mortality Rate in High-Risk Patients? It Is Time for Large Mendelian Randomization Studies.

Trischitta V, Di Paola R.

Am J Cardiol. 2018 Sep 1;122(5):910. doi: 10.1016/j.amjcard.2018.04.063. Epub 2018 Jun 2. No abstract available.

PMID:
30049458
13.

The Adiponectin Paradox for All-Cause and Cardiovascular Mortality.

Menzaghi C, Trischitta V.

Diabetes. 2018 Jan;67(1):12-22. doi: 10.2337/dbi17-0016. Erratum in: Diabetes. 2018 Dec;67(12):2710.

14.

Familial diabetes of adulthood: A bin of ignorance that needs to be addressed.

Prudente S, Ludovico O, Trischitta V.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1053-1059. doi: 10.1016/j.numecd.2017.10.017. Epub 2017 Oct 26. Review.

PMID:
29174219
15.

Insights From Molecular Characterization of Adult Patients of Families With Multigenerational Diabetes.

Pezzilli S, Ludovico O, Biagini T, Mercuri L, Alberico F, Lauricella E, Dallali H, Capocefalo D, Carella M, Miccinilli E, Piscitelli P, Scarale MG, Mazza T, Trischitta V, Prudente S.

Diabetes. 2018 Jan;67(1):137-145. doi: 10.2337/db17-0867. Epub 2017 Oct 9.

16.

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells.

Caporarello N, Parrino C, Trischitta V, Frittitta L.

PLoS One. 2017 Aug 2;12(8):e0181190. doi: 10.1371/journal.pone.0181190. eCollection 2017.

17.

Some Doubts About the Mantra on the Deleterious Cardiovascular Effects of Sulfonylureas.

Trischitta V, Prudente S.

Diabetes. 2017 Aug;66(8):2069-2071. doi: 10.2337/dbi17-0023. No abstract available.

18.

Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.

Prudente S, Di Paola R, Pezzilli S, Garofolo M, Lamacchia O, Filardi T, Mannino GC, Mercuri L, Alberico F, Scarale MG, Sesti G, Morano S, Penno G, Cignarelli M, Copetti M, Trischitta V.

Pharmacogenomics J. 2018 May 22;18(3):431-435. doi: 10.1038/tpj.2017.32. Epub 2017 Jul 11.

PMID:
28696414
19.
20.

On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus.

Lamacchia O, Fontana A, Pacilli A, Copetti M, Fariello S, Garofolo M, Penno G, Trischitta V, De Cosmo S, Cignarelli M.

Atherosclerosis. 2017 May;260:20-26. doi: 10.1016/j.atherosclerosis.2017.03.008. Epub 2017 Mar 9.

PMID:
28334637
21.

Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals.

Menzaghi C, Marucci A, Antonucci A, De Bonis C, Ortega Moreno L, Salvemini L, Copetti M, Trischitta V, Di Paola R.

Sci Rep. 2017 Mar 14;7:44337. doi: 10.1038/srep44337.

22.

Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data.

Fontana A, Ortega Moreno L, Lamacchia O, De Bonis C, Salvemini L, De Cosmo S, Cignarelli M, Copetti M, Trischitta V, Menzaghi C.

Sci Rep. 2017 Mar 3;7(1):61. doi: 10.1038/s41598-017-00138-3.

23.

GALNT2 effect on HDL-cholesterol and triglycerides levels in humans: Evidence of pleiotropy?

Di Paola R, Marucci A, Trischitta V.

Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):281-282. doi: 10.1016/j.numecd.2016.11.006. Epub 2016 Nov 23.

PMID:
28153384
24.

Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology.

Buzzetti R, Prudente S, Copetti M, Dauriz M, Zampetti S, Garofolo M, Penno G, Trischitta V.

Nutr Metab Cardiovasc Dis. 2017 Feb;27(2):99-114. doi: 10.1016/j.numecd.2016.08.005. Epub 2016 Aug 26. Review.

PMID:
28063875
25.

Acute triventricular hydrocephalus caused by choroid plexus cysts: a diagnostic and neurosurgical challenge.

Spennato P, Chiaramonte C, Cicala D, Donofrio V, Barbarisi M, Nastro A, Mirone G, Trischitta V, Cinalli G.

Neurosurg Focus. 2016 Nov;41(5):E9.

PMID:
27798987
26.

The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus.

Pacilli A, Prudente S, Copetti M, Fontana A, Mercuri L, Bacci S, Marucci A, Alberico F, Viti R, Palena A, Lamacchia O, Cignarelli M, De Cosmo S, Trischitta V.

Endocrine. 2016 Oct;54(1):38-46. Epub 2016 Mar 8.

PMID:
26956846
27.

Childhood acute basilar artery thrombosis successfully treated with mechanical thrombectomy using stent retrievers: case report and review of the literature.

Nicosia G, Cicala D, Mirone G, Spennato P, Trischitta V, Ruggiero C, Guarneri G, Muto M, Cinalli G.

Childs Nerv Syst. 2017 Feb;33(2):349-355. doi: 10.1007/s00381-016-3259-z. Epub 2016 Oct 4. Review.

PMID:
27704247
28.

The rs12917707 polymorphism at the UMOD locus and glomerular filtration rate in individuals with type 2 diabetes: evidence of heterogeneity across two different European populations.

Prudente S, Di Paola R, Copetti M, Lucchesi D, Lamacchia O, Pezzilli S, Mercuri L, Alberico F, Giusti L, Garofolo M, Penno G, Cignarelli M, De Cosmo S, Trischitta V.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1718-1722. doi: 10.1093/ndt/gfw262.

PMID:
27448670
29.

The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity.

Ortega Moreno L, Lamacchia O, Fontana A, Copetti M, Salvemini L, De Bonis C, Cignarelli M, Trischitta V, Menzaghi C.

Atherosclerosis. 2016 Jul;250:23-9. doi: 10.1016/j.atherosclerosis.2016.04.028. Epub 2016 Apr 27.

PMID:
27175608
30.

Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes.

Ortega Moreno L, Copetti M, Fontana A, De Bonis C, Salvemini L, Trischitta V, Menzaghi C.

Cardiovasc Diabetol. 2016 Jan 27;15:17. doi: 10.1186/s12933-016-0339-z.

31.

Patient/disease features and glycemic targets in type 2 diabetes: Where do we stand?

Pacilli A, Fallarino M, Massa M, Filardi T, De Cosmo S, Morano S, Trischitta V.

Acta Diabetol. 2016 Aug;53(4):673-5. doi: 10.1007/s00592-015-0833-x. Epub 2016 Jan 11. No abstract available.

PMID:
26754323
32.

The paradoxical association of adiponectin with mortality rate in patients with type 2 diabetes: evidence of synergism with kidney function.

Ortega Moreno L, Lamacchia O, Salvemini L, De Bonis C, De Cosmo S, Cignarelli M, Trischitta V, Menzaghi C.

Atherosclerosis. 2016 Feb;245:222-7. doi: 10.1016/j.atherosclerosis.2015.12.026. Epub 2015 Dec 22.

PMID:
26735588
33.

The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol.

Barchetta I, Capoccia D, Baroni MG, Buzzetti R, Cavallo MG, De Cosmo S, Leonetti F, Leotta S, Morano S, Morviducci L, Prudente S, Pugliese G, Trischitta V; SUMMER Study in Diabetes Group.

Nutr Metab Cardiovasc Dis. 2016 Feb;26(2):103-8. doi: 10.1016/j.numecd.2015.09.009. Epub 2015 Oct 9.

PMID:
26698225
34.

A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.

Testa A, Prudente S, Leonardis D, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Rizza S, Mallamaci F, Federici M, Trischitta V, Zoccali C.

Nutr Metab Cardiovasc Dis. 2015 Dec;25(12):1087-94. doi: 10.1016/j.numecd.2015.08.004. Epub 2015 Aug 21. Review.

PMID:
26607700
35.

The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations.

Prudente S, Trischitta V.

Biochem Soc Trans. 2015 Oct;43(5):1108-11. doi: 10.1042/BST20150115. Review.

PMID:
26517932
36.

Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes.

Ortega Moreno L, Lamacchia O, Copetti M, Salvemini L, De Bonis C, De Cosmo S, Cignarelli M, Trischitta V, Menzaghi C.

PLoS One. 2015 Oct 14;10(10):e0140631. doi: 10.1371/journal.pone.0140631. eCollection 2015.

37.

Strong evidence of sexual dimorphic effect of adiposity excess on insulin sensitivity.

Marucci A, Menzaghi C, Copetti M, Vinciguerra F, Baratta R, Salvemini L, Morini E, Frittitta L, Di Paola R, Trischitta V.

Acta Diabetol. 2015 Oct;52(5):991-8. doi: 10.1007/s00592-015-0804-2. Epub 2015 Aug 25.

PMID:
26302880
38.

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus.

Ludovico O, Carella M, Bisceglia L, Basile G, Mastroianno S, Palena A, De Cosmo S, Copetti M, Prudente S, Trischitta V.

PLoS One. 2015 Aug 19;10(8):e0135855. doi: 10.1371/journal.pone.0135855. eCollection 2015.

39.

Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.

Prudente S, Bailetti D, Mendonca C, Mannino GC, Fontana A, Andreozzi F, Hastings T, Mercuri L, Alberico F, Basile G, Copetti M, Sesti G, Doria A, Trischitta V.

Atherosclerosis. 2015 Sep;242(1):334-9. doi: 10.1016/j.atherosclerosis.2015.07.030. Epub 2015 Jul 17.

40.

GALNT2 mRNA levels are associated with serum triglycerides in humans.

Marucci A, Mangiacotti D, Trischitta V, Di Paola R.

Endocrine. 2016 Jul;53(1):331-4. doi: 10.1007/s12020-015-0705-8. Epub 2015 Aug 4. No abstract available.

PMID:
26239958
41.

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus.

Prudente S, Jungtrakoon P, Marucci A, Ludovico O, Buranasupkajorn P, Mazza T, Hastings T, Milano T, Morini E, Mercuri L, Bailetti D, Mendonca C, Alberico F, Basile G, Romani M, Miccinilli E, Pizzuti A, Carella M, Barbetti F, Pascarella S, Marchetti P, Trischitta V, Di Paola R, Doria A.

Am J Hum Genet. 2015 Jul 2;97(1):177-85. doi: 10.1016/j.ajhg.2015.05.011. Epub 2015 Jun 11.

42.

Target values of cardiovascular risk factors are not associated with all-cause mortality in patients with type 2 diabetes mellitus.

Pacilli A, Lamacchia O, Fontana A, Copetti M, Cignarelli M, Trischitta V, De Cosmo S.

PLoS One. 2015 Apr 30;10(4):e0124536. doi: 10.1371/journal.pone.0124536. eCollection 2015.

43.

Serum resistin and glomerular filtration rate in patients with type 2 diabetes.

Moreno LO, Salvemini L, Mendonca C, Copetti M, De Bonis C, De Cosmo S, Doria A, Trischitta V, Menzaghi C.

PLoS One. 2015 Mar 26;10(3):e0119529. doi: 10.1371/journal.pone.0119529. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0127250.

44.

Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis.

Fontana A, Spadaro S, Copetti M, Spoto B, Salvemini L, Pizzini P, Frittitta L, Mallamaci F, Pellegrini F, Trischitta V, Menzaghi C.

PLoS One. 2015 Mar 20;10(3):e0120419. doi: 10.1371/journal.pone.0120419. eCollection 2015. Review.

45.

Cortical gluing and Ringer lactate solution inflation to avoid cortical mantle collapse and subdural fluid collections in pediatric neurosurgery: safety and feasibility.

Mirone G, Ruggiero C, Spennato P, Aliberti F, Trischitta V, Cinalli G.

Childs Nerv Syst. 2015 Jun;31(6):945-51. doi: 10.1007/s00381-015-2660-3. Epub 2015 Feb 26.

PMID:
25715841
46.

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes.

Prudente S, Shah H, Bailetti D, Pezzolesi M, Buranasupkajorn P, Mercuri L, Mendonca C, De Cosmo S, Niewczas M, Trischitta V, Doria A.

Diabetes. 2015 Jul;64(7):2658-63. doi: 10.2337/db14-1653. Epub 2015 Feb 12.

47.

Sex-specific effect of BMI on insulin sensitivity and TNF-α expression.

Marucci A, Mangiacotti D, di Mauro L, Antonacci M, Trischitta V, Di Paola R.

Acta Diabetol. 2015 Apr;52(2):413-6. doi: 10.1007/s00592-014-0696-6. Epub 2014 Dec 25. No abstract available.

PMID:
25539882
48.

Joint effect of insulin signaling genes on all-cause mortality.

Menzaghi C, Fontana A, Copetti M, Rizza S, Spoto B, Buranasupkajorn P, Tripepi G, Marucci A, Bailetti D, Hastings T, Testa A, Mendonca C, Mallamaci F, De Cosmo S, Bacci S, Federici M, Doria A, Zoccali C, Trischitta V.

Atherosclerosis. 2014 Dec;237(2):639-44. doi: 10.1016/j.atherosclerosis.2014.10.005. Epub 2014 Oct 24.

49.

Low prevalence of HNF1A mutations after molecular screening of multiple MODY genes in 58 Italian families recruited in the pediatric or adult diabetes clinic from a single Italian hospital.

Delvecchio M, Ludovico O, Menzaghi C, Di Paola R, Zelante L, Marucci A, Grasso V, Trischitta V, Carella M, Barbetti F, Gallo F, Coccioli MS, Zecchino C, Faienza MF, Cardinale G, Franzese A, Mozzillo E, Iafusco D, Zanfardino A.

Diabetes Care. 2014 Dec;37(12):e258-60. doi: 10.2337/dc14-1788. No abstract available.

PMID:
25414397
50.

Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism.

Menzaghi C, Xu M, Salvemini L, De Bonis C, Palladino G, Huang T, Copetti M, Zheng Y, Li Y, Fini G, Hu FB, Bacci S, Qi L, Trischitta V.

Cardiovasc Diabetol. 2014 Sep 10;13:130. doi: 10.1186/s12933-014-0130-y.

Supplemental Content

Loading ...
Support Center